Mark Coleman, Director: Axsome Therapeutics AXSM Planned sale · Filed 25/05/20

Trade details

Type: Planned sale notice
Stock: Axsome Therapeutics AXSM
Person: Mark ColemanDirector
Planned sale date: 25/05/20
Filed: 25/05/20

$322.5K to be sold

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/20~25/06/19

Mark Coleman's recent trades

Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 05/29
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 06/01
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.2M
5,537 sh
$1.2M
Filed 06/02
Traded 06/02

Mark Coleman, Director — plans to sell 3,000 sh of Axsome Therapeutics AXSM · $322.5K · around 05/20 | Whalegun